Eli Lilly and Co (LLY)
776.67
-1.10
(-0.14%)
USD |
NYSE |
May 08, 10:43
Eli Lilly Gross Profit Margin (Quarterly): 80.91% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 80.91% |
| December 31, 2023 | 80.88% |
| September 30, 2023 | 80.42% |
| June 30, 2023 | 78.26% |
| March 31, 2023 | 76.63% |
| December 31, 2022 | 78.80% |
| September 30, 2022 | 77.25% |
| June 30, 2022 | 77.95% |
| March 31, 2022 | 73.47% |
| December 31, 2021 | 74.37% |
| September 30, 2021 | 78.87% |
| June 30, 2021 | 71.02% |
| March 31, 2021 | 72.40% |
| December 31, 2020 | 76.88% |
| September 30, 2020 | 76.89% |
| June 30, 2020 | 77.78% |
| March 31, 2020 | 79.26% |
| December 31, 2019 | 79.02% |
| September 30, 2019 | 78.55% |
| June 30, 2019 | 80.04% |
| March 31, 2019 | 77.64% |
| December 31, 2018 | 79.96% |
| September 30, 2018 | 78.28% |
| June 30, 2018 | 77.90% |
| March 31, 2018 | 76.54% |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | 71.96% |
| June 30, 2017 | 73.01% |
| March 31, 2017 | 74.22% |
| December 31, 2016 | 73.59% |
| September 30, 2016 | 73.02% |
| June 30, 2016 | 72.89% |
| March 31, 2016 | 72.81% |
| December 31, 2015 | 74.16% |
| September 30, 2015 | 75.06% |
| June 30, 2015 | 75.53% |
| March 31, 2015 | 74.32% |
| December 31, 2014 | 75.53% |
| September 30, 2014 | 74.01% |
| June 30, 2014 | 75.90% |
| March 31, 2014 | 73.89% |
| December 31, 2013 | 76.13% |
| September 30, 2013 | 79.25% |
| June 30, 2013 | 80.35% |
| March 31, 2013 | 79.32% |
| December 31, 2012 | 79.05% |
| September 30, 2012 | 77.89% |
| June 30, 2012 | 79.53% |
| March 31, 2012 | 78.62% |
| December 31, 2011 | 78.14% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
71.02%
Minimum
Jun 2021
80.91%
Maximum
Mar 2024
77.48%
Average
78.10%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 57.03% |
| Biogen Inc | 76.33% |
| Madrigal Pharmaceuticals Inc | -- |
| Vertex Pharmaceuticals Inc | 87.27% |
| Viking Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 53.37% |
| Return on Assets | 10.45% |
| Return on Invested Capital | 18.40% |
| Profit Margin (Quarterly) | 25.58% |
| Operating Margin (Quarterly) | 31.20% |
| Return on Net Operating Assets | 14.99% |